Biogen Inc.BIIBNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-26.90%
↓ 192% below average
Average (39q)
29.18%
Historical baseline
Range
High:493.62%
Low:-124.31%
CAGR
+2.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -26.90% |
| Q2 2025 | 163.64% |
| Q1 2025 | -9.84% |
| Q4 2024 | -31.46% |
| Q3 2024 | -33.42% |
| Q2 2024 | 47.97% |
| Q1 2024 | 57.56% |
| Q4 2023 | 465.96% |
| Q3 2023 | -111.49% |
| Q2 2023 | 52.04% |
| Q1 2023 | -29.58% |
| Q4 2022 | -51.40% |
| Q3 2022 | 8.41% |
| Q2 2022 | 251.94% |
| Q1 2022 | -17.93% |
| Q4 2021 | 13.06% |
| Q3 2021 | -26.00% |
| Q2 2021 | 11.11% |
| Q1 2021 | 15.88% |
| Q4 2020 | -47.87% |
| Q3 2020 | -53.44% |
| Q2 2020 | 18.52% |
| Q1 2020 | 0.00% |
| Q4 2019 | -3.57% |
| Q3 2019 | 7.01% |
| Q2 2019 | 9.48% |
| Q1 2019 | 51.27% |
| Q4 2018 | -33.89% |
| Q3 2018 | 71.53% |
| Q2 2018 | -24.68% |
| Q1 2018 | 493.62% |
| Q4 2017 | -124.31% |
| Q3 2017 | 42.51% |
| Q2 2017 | 17.29% |
| Q1 2017 | 15.67% |
| Q4 2016 | -36.44% |
| Q3 2016 | -1.46% |
| Q2 2016 | 7.88% |
| Q1 2016 | 17.77% |
| Q4 2015 | -9.38% |